share_log

Novavax | 144: Notice of proposed sale of securities pursuant to Rule 144

Novavax | 144: Notice of proposed sale of securities pursuant to Rule 144

诺瓦瓦克斯医药 | 144:拟议出售证券
美股sec公告 ·  06/18 16:15
Moomoo AI 已提取核心信息
Novavax Inc Director James F. Young is set to sell 15,000 shares of common stock on 06/18/2024, with an aggregate market value of $205,650. The shares to be sold were acquired through stock plan activity, with 7,590 shares obtained on 06/25/2021 and an additional 7,410 shares on 07/01/2021, both from the issuer. There is no recent transaction history reported for the past three months.
Novavax Inc Director James F. Young is set to sell 15,000 shares of common stock on 06/18/2024, with an aggregate market value of $205,650. The shares to be sold were acquired through stock plan activity, with 7,590 shares obtained on 06/25/2021 and an additional 7,410 shares on 07/01/2021, both from the issuer. There is no recent transaction history reported for the past three months.
Novavax Inc董事James F. Young计划于2024年06月18日出售价值205650美元的共15000股普通股。这些股票是通过股票计划活动获得的,其中7590股是在2021年06月25日从发行人处获得的,另外7410股是在2021年07月01日获得的。过去三个月没有报告任何最近的交易记录。
Novavax Inc董事James F. Young计划于2024年06月18日出售价值205650美元的共15000股普通股。这些股票是通过股票计划活动获得的,其中7590股是在2021年06月25日从发行人处获得的,另外7410股是在2021年07月01日获得的。过去三个月没有报告任何最近的交易记录。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息